|
1
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma QP, Jiang Q, Pu Q, Zhang X, Yang W,
Wang Y, Ye S, Wu S, Zhong G, Ren J, et al: MicroRNA-143 inhibits
migration and invasion of human non-small-cell lung cancer and its
relative mechanism. Int J Biol Sci. 9:680–692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song T, Zhang X, Wang C, Wu Y, Dong J, Gao
J, Cai W and Hong B: Expression of miR-143 reduces growth and
migration of human bladder carcinoma cells by targeting
cyclooxygenase-2. Asian Pac J Cancer Prev. 12:929–933.
2011.PubMed/NCBI
|
|
5
|
Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z,
Li P, Zhang W, Wu H, Feng N, et al: mir-143 decreases prostate
cancer cells proliferation and migration and enhances their
sensitivity to docetaxel through suppression of KRAS. Mol Cell
Biochem. 350:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu XL, Cheng B, Li PY, Huang HJ, Zhao Q,
Dan ZL, Tian DA and Zhang P: MicroRNA-143 suppresses gastric cancer
cell growth and induces apoptosis by targeting COX-2. World J
Gastroenterol. 19:7758–7765. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Osaki M, Takeshita F, Sugimoto Y, Kosaka
N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T,
et al: MicroRNA-143 regulates human osteosarcoma metastasis by
regulating matrix metalloprotease-13 expression. Mol Ther.
19:1123–1130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang YY, Kuo WH, Hung JH, Lee CY, Lee YH,
Chang YC, Lin WC, Shen CY, Huang CS, Hsieh FJ, et al: Deregulated
microRNAs in triple-negative breast cancer revealed by deep
sequencing. Mol Cancer. 14:362015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Akao Y, Nakagawa Y, Kitade Y, Kinoshita T
and Naoe T: Downregulation of microRNAs-143 and −145 in B-cell
malignancies. Cancer Sci. 98:1914–1920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Noguchi S, Yasui Y, Iwasaki J, Kumazaki M,
Yamada N, Naito S and Akao Y: Replacement treatment with
microRNA-143 and −145 induces synergistic inhibition of the growth
of human bladder cancer cells by regulating PI3K/Akt and MAPK
signaling pathways. Cancer Lett. 328:353–361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ahmad I, Singh LB, Yang ZH, Kalna G,
Fleming J, Fisher G, Cooper C, Cuzick J, Berney DM, Møller H, et
al: Mir143 expression inversely correlates with nuclear ERK5
immunoreactivity in clinical prostate cancer. Br J Cancer.
108:149–154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hou LJ and Zhai JJ: Aberrant expression
profile of translationally controlled tumor protein and
tumor-suppressive microRNAs in cervical cancer. J BUON.
20:1504–1509. 2015.PubMed/NCBI
|
|
13
|
Honegger A, Schilling D, Bastian S,
Sponagel J, Kuryshev V, Sültmann H, Scheffner M, Hoppe-Seyler K and
Hoppe-Seyler F: Dependence of intracellular and exosomal microRNAs
on viral E6/E7 oncogene expression in HPV-positive tumor cells.
PLoS Pathog. 11:e10047122015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang XH, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pinweha P, Rattanapornsompong K,
Charoensawan V and Jitrapakdee S: MicroRNAs and oncogenic
transcriptional regulatory networks controlling metabolic
reprogramming in cancers. Comput Struct Biotechnol J. 14:223–233.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mekenkamp LJ, Tol J, Dijkstra JR, de
Krijger I, Vink-Börger ME, van Vliet S, Teerenstra S, Kamping E,
Verwiel E, Koopman M, et al: Beyond KRAS mutation status: Influence
of KRAS copy number status and microRNAs on clinical outcome to
cetuximab in metastatic colorectal cancer patients. BMC Cancer.
12:2922012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peng X, Guo W, Liu T, Wang X, Tu X, Xiong
D, Chen S, Lai Y, Du H, Chen G, et al: Identification of miRs-143
and-145 that is associated with bone metastasis of prostate cancer
and involved in the regulation of EMT. PLoS One. 6:e203412011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lochhead PA, Gilley R and Cook SJ: ERK5
and its role in tumour development. Biochem Soc Trans. 40:251–256.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Clapé C, Fritz V, Henriquet C, Apparailly
F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S and
Fajas L: miR-143 interferes with ERK5 signaling, and abrogates
prostate cancer progression in mice. PLoS One. 4:e75422009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takaoka Y, Shimizu Y, Hasegawa H, Ouchi Y,
Qiao S, Nagahara M, Ichihara M, Lee JD, Adachi K, Hamaguchi M and
Iwamoto T: Forced expression of miR-143 represses ERK5/c-Myc and
p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min)
mice. PLoS One. 7:e421372012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Borralho PM, Simões AE, Gomes SE, Lima RT,
Carvalho T, Ferreira DM, Vasconcelos MH, Castro RE and Rodrigues
CM: miR-143 overexpression impairs growth of human colon carcinoma
xenografts in mice with induction of apoptosis and inhibition of
proliferation. PLoS One. 6:e237872011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakagawa Y, Iinuma M, Naoe T, Nozawa Y and
Akao Y: Characterized mechanism of alpha-mangostin-induced cell
death: Caspase-independent apoptosis with release of endonuclease-G
from mitochondria and increased miR-143 expression in human
colorectal cancer DLD-1 cells. Bioorg Med Chem. 15:5620–5628. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sasaki T, Kojima H, Kishimoto R, Ikeda A,
Kunimoto H and Nakajima K: Spatiotemporal regulation of c-Fos by
ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol
Cell. 24:63–75. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kajimoto K, Naraba H and Iwai N: MicroRNA
and 3T3-L1 pre-adipocyte differentiation. RNA. 12:1626–1632. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Corney DC, Flesken-Nikitin A, Godwin AK,
Wang W and Nikitin AY: MicroRNA-34b and MicroRNA-34c are targets of
p53 and cooperate in control of cell proliferation and
adhesion-independent growth. Cancer Res. 67:8433–8438. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
Identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak and Schmittgen, . Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu L, Yu X, Guo X, Tian Z, Su M, Long Y,
Huang C, Zhou F, Liu M, Wu X and Wang X: miR-143 is downregulated
in cervical cancer and promotes apoptosis and inhibits tumor
formation by targeting Bcl-2. Mol Med Rep. 5:753–760.
2012.PubMed/NCBI
|
|
29
|
Simões AE, Rodrigues CM and Borralho PM:
The MEK5/ERK5 signalling pathway in cancer: A promising novel
therapeutic target. Drug Discov Today. S1359-S6446(16): 30228–8.
2016.
|
|
30
|
Nithianandarajah-Jones GN, Wilm B,
Goldring CE, Müller J and Cross MJ: ERK5: Structure, regulation and
function. Cell Signal. 24:2187–2196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen B, Li H, Zeng X, Yang P, Liu X, Zhao
X and Liang S: Roles of microRNA on cancer cell metabolism. J
Transl Med. 10:2282012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Truta A, Popon TA, Saraci G, Ghervan L and
Pop IV: Novel non invasive diagnostic strategies in bladder cancer.
Clujul Med. 89:187–192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Goto Y, Kurozumi A, Enokida H, Ichikawa T
and Seki N: Functional significance of aberrantly expressed
microRNAs in prostate cancer. Int J Urol. 22:242–252. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Banno K, Iida M, Yanokura M, Kisu I, Iwata
T, Tominaga E, Tanaka K and Aoki D: MicroRNA in cervical cancer:
OncomiRs and tumor suppressor miRs in diagnosis and treatment.
Scientific World Journal. 2014:1780752014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pan Y, Meng M, Zhang G, Han H and Zhou Q:
Oncogenic microRNAs in the genesis of leukemia and lymphoma. Curr
Pharm Des. 20:5260–5267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bai L, Mao R, Wang J, Ding L, Jiang S, Gao
C, Kang H, Chen X, Sun X and Xu J: ERK1/2 promoted proliferation
and inhibited apoptosis of human cervical cancer cells and
regulated the expression of c-Fos and c-Jun proteins. Med Oncol.
32:572015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li
JJ, Röcken C, Ebert MP, Kwok TT and Sung JJ: MicroRNA-143 targets
DNA methyltransferases 3A in colorectal cancer. Br J Cancer.
101:699–706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin T, Dong W, Huang J, Pan Q, Fan X,
Zhang C and Huang L: MicroRNA-143 as a tumor suppressor for bladder
cancer. J Urol. 181:1372–1380. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zen K, Yasui K, Nakajima T, Zen Y, Zen K,
Gen Y, Mitsuyoshi H, Minami M, Mitsufuji S, Tanaka S, et al: ERK5
is a target for gene amplification at 17p11 and promotes cell
growth in hepatocellular carcinoma by regulating mitotic entry.
Genes Chromosomes Cancer. 48:109–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lui WO, Pourmand N, Patterson BK and Fire
A: Patterns of known and novel small RNAs in human cervical cancer.
Cancer Res. 67:6031–6043. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Deftereos G, Corrie SR, Feng QH, Morihara
J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and
mir-143 in cervical specimens ranging from histologically normal
through to invasive cervical cancer. PLoS One. 6:e284232011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cude K, Wang YP, Choi HJ, Hsuan SL, Zhang
H, Wang CY and Xia Z: Regulation of the G2-M cell cycle progression
by the ERK5-NFkappa B signaling pathway. J Cell Biol. 177:253–264.
2007. View Article : Google Scholar : PubMed/NCBI
|
